Should off-label drugs be included as comparators in pharmacoeconomic studies?
Pharmacoeconomics
.
2014 Nov;32(11):1035-7.
doi: 10.1007/s40273-014-0222-2.
Authors
Surrey M Walton
1
,
Glen T Schumock
Affiliation
1
Department of Pharmacy Systems, Outcomes, and Policy, UIC, 833 S. Wood Street (M/C 871), Chicago, IL, 60612, USA, walton@uic.edu.
PMID:
25270597
DOI:
10.1007/s40273-014-0222-2
No abstract available
Publication types
Editorial
MeSH terms
Costs and Cost Analysis / economics
Costs and Cost Analysis / methods*
Economics, Pharmaceutical*
Humans
Off-Label Use / economics*